Trio Pharmaceuticals
San Diego
About Trio Pharmaceuticals
Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors. These drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. The company was founded in 2018 and is headquartered in San Diego, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.8M
- Funding stage: Seed
- Last round: Seed (Dec 2024)
- Website: triopharmaceuticals.com
- Phone: +1-765-490-0874
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/trio-pharmaceuticals-5653 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.